Table 1: Experimental groups.

Injection receivedNumber of injections

Group 1
Ad-VB6 mixed with Matrigel, no cells 4 SQ injections for 3 and 4 week time points
Group 2 Noninfected MMCs and Ad-VB6 mixed with Matrigel
4 SQ injections for 3 and 4 week time points
Group 3MMCs infected with Ad-VB6 and mixed with Matrigel
3 SQ injections for 3 and 4 week time points

MMCs: mixed bone marrow cells; Ad-VB6: pAd-Shuttle-hBMP6-IRES-hVEGF-IRES-hrGFP-1; SQ: subcutaneous.